Brazil vs Eritrea: Share of the population living with HIV receiving antiretroviral therapy
Brazil
72.7%
in 2024
Eritrea
71.9%
in 2024
Brazil rank
72nd
Eritrea rank
74th
Share of the population living with HIV receiving antiretroviral therapy over time
- Brazil
- Eritrea
How they compare
Brazil currently reports 72.7% against 71.9% in Eritrea, a difference of 0.8%.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Eritrea ahead.
Brazil ranks 72nd and Eritrea ranks 74th of 149 countries.
Across the 4 decades both report, Brazil averaged higher in 3 and Eritrea in 1.
Head to head by decade
| Decade | Brazil | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.5% | 0.0% | 5.5% | Brazil |
| 2000s | 42.8% | 5.2% | 37.6% | Brazil |
| 2010s | 60.0% | 51.6% | 8.4% | Brazil |
| 2020s | 70.1% | 70.8% | 0.7% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Brazil or Eritrea?
- Brazil, at 72.7% against 71.9% in Eritrea as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Brazil and Eritrea?
- 0.8%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Eritrea?
- 35 years are reported by both, from 1990 to 2024.
- How do Brazil and Eritrea rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Brazil ranks 72nd and Eritrea ranks 74th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.